Metagenomi, Inc (MGX) - Net Sales Margin

MGX (Metagenomi) - company brandmark

The net margin structure demonstrates profitability dynamics, where the -1329.30 level reflects the current value of the metric. Metagenomi, Inc. (MGX) possesses significant scientific weight in the development of precision CRISPR editing. Searching for natural enzymes via metagenomics allows the company to bypass patents and create safe therapeutics. A high technological barrier to entry and a protected intellectual property base provide the company with a sustainable competitive advantage.

MGX: Metagenomi, Inc. Company Sales Margin 02/21/2024 - 11/20/2026

Metric breakdowns and analytics for Metagenomi, Inc. (MGX)

- market value and analyst target forecast:
Summary company analysis:Metagenomi, Inc - MGX
Flagship merchandise of Metagenomi Therapeutics

Net margin determines the portion of profit in every dollar of revenue, serving as a key measure of commercial efficiency. Analyzing the company's sales margins allows for the real-time tracking of changes in cost structure without quarterly delays. The metric is calculated as the ratio of net income to total sales. For Metagenomi, Inc. (MGX), this trend reflects the scientific team's ability to optimize expenses for clinical platforms. Transparent risk management helps investors assess the resilience of the business model during long-term partnerships with pharma behemoths.

Key competitors

TEM: Net Sales Margin|Net Profitability Margin Qiagen QGEN|IONS (Isis Pharmaceuticals) - Net Sales Margin|Repligen Inc. - Net Profit Margin|Net Sales Margin RNA|CRSP - Net Margin|GeneDx - Return on Sales by Net Profit|Net Profit Rate RARE|Beam Tx - Net Sales Margin|SRPT - Net Sales Margin|TWST (Twist Bio) - Return on Sales by Net Profit|Net Return on Sales TXG|Return on Sales by Net Profit NTLA|Stoke Therapeutics Inc (STOK) - Company Sales Margin|Net Sales Margin BLFS|Net Margin WVE (Wave Life Sciences Corp)|Net Margin Maze Therapeutics MAZE|Net Profit Rate SION|PRME - Net Margin|Company Sales Margin Taysha TSHA|QURE: Net Sales Margin|Return on Sales by Net Profit MeiraGTx PLC|RGNX (REGENXBIO Inc) - Net Sales Margin|solidbio.com (SLDB) - Company Sales Margin|Net Margin Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Net Return on Sales|Benitec Biopharma - Return on Sales by Net Profit|DSGN: Net Return on Sales|RCKT: Return on Sales by Net Profit|FDMT - Net Sales Margin|LXEO: Net Sales Margin|Korro Bio Inc. - Net Profit Rate|EDIT (editasmedicine.com) - Net Sales Margin|Net Margin SLN|Net Margin ProQR Therapeutics NV (PRQR)|Codexis - Net Return on Sales|Net Margin Sangamo SGMO|NAUT: Net Return on Sales|Precision BioSciences Inc. - Net Sales Margin|GBIO - Net Sales Margin|BOLD: Net Sales Margin|Net Return on Sales XCUR|Net Margin Imunon|Phio Pharmaceuticals - Net Profit Margin|Net Margin Mustang Bio, Inc. (MBIO)|Company Sales Margin TransCode Therapeutics, Inc.|Net Margin Bionano Genomics BNGO|Net Profit Rate APDN|BLUE - Net Margin|Net Profit Margin IPA|Omega Therapeutics, Inc. (OMGA) - Net Margin|Singular Genomics Corp (OMIC) - Net Sales Margin|RGLS (Regulus Therapeutics, Inc.) - Net Sales Margin|SYRS: Net Profit Rate|Return on Sales by Net Profit TBIO (Telesis Bio Inc.)|Net Sales Margin TRACON Pharmaceuticals Inc. (TCON)|Net Margin Unity Bio UBX